LISBON CONFERENCES
Meander up one in all Lisbon’s loftiest hills to the Moorish Alfama neighbourhood, wherever sunset-amber walls and dirty lanes orbit the Arabic-cum-medieval castle that looms, omnipresent, over the terracotta rooftops of town. Or witness the simplest of this bygone heritage by wandering through the Baixa district, wherever old herbalists, haberdashers and tailors rub shoulders within the baroque streets of the ornate centre. within the summer months, lisbon swelters beneath a cerulean blue dome. ‘A praia’ (to the beach) sings out from the city’s sun-kissed, flower blossomed streets as surf boards area unit stacked on high of cars and everybody makes for the beach ‘burbs of Cascais and Estoril – twenty minutes’ drive from the city-center. The aim being to cool down off in the frosty Atlantic, get some sand between their toes, and tuck into the sea-coast classic of a plate of garlicky ameijoas (clams) washed down with a glass of brain-freeze cold lager.
Market Analysis & Funding for Pharma | Nursing | Immunology | Neuroscience | Cancer | Engineering | Cardiology
Pharmaceuticals
Portugal ' s expansionary budget can still support rising domestic consumption indices, which will contribute to modest pharmaceutical market growth rates over a multi-quarter horizon. In May 2016, a comprehensive national health survey reported a higher burden of disease than previously estimated in Portugal obesity 28.7% hypertension 36% Diabetes 9.8% and hypercholesterolemia rates of 52.3%, reports. Portugal’s pharmaceutical market is projected to show modest growth in the near future, from a value of US$5.1 billion (€3.9 billion) in 2012 to approximately US$5.6 billion (€4.4 billion) by 2020, at a Compound Annual Growth Rate (CAGR) of 1.2%. The medical device market is projected to grow at a CAGR of 3.1% from US$1.5 billion in 2012 to US$2 billion in 2020.